<?xml version="1.0" encoding="UTF-8"?>
<ref id="bjh15394-bib-0033">
 <mixed-citation publication-type="journal" id="bjh15394-cit-0033">
  <string-name>
   <surname>Ludwig</surname>, 
   <given-names>H.</given-names>
  </string-name>, 
  <string-name>
   <surname>Greil</surname>, 
   <given-names>R.</given-names>
  </string-name>, 
  <string-name>
   <surname>Masszi</surname>, 
   <given-names>T.</given-names>
  </string-name>, 
  <string-name>
   <surname>Spicka</surname>, 
   <given-names>I.</given-names>
  </string-name>, 
  <string-name>
   <surname>Shpilberg</surname>, 
   <given-names>O.</given-names>
  </string-name>, 
  <string-name>
   <surname>Hajek</surname>, 
   <given-names>R.</given-names>
  </string-name>, 
  <string-name>
   <surname>Dmoszynska</surname>, 
   <given-names>A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Paiva</surname>, 
   <given-names>B.</given-names>
  </string-name>, 
  <string-name>
   <surname>Vidriales</surname>, 
   <given-names>M.B.</given-names>
  </string-name>, 
  <string-name>
   <surname>Esteves</surname>, 
   <given-names>G.</given-names>
  </string-name>, 
  <string-name>
   <surname>Stoppa</surname>, 
   <given-names>A.M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Robinson</surname>, 
   <given-names>D.</given-names>
   <suffix>Jr</suffix>
  </string-name>, 
  <string-name>
   <surname>Chaturvedi</surname>, 
   <given-names>S.</given-names>
  </string-name>, 
  <string-name>
   <surname>Ataman</surname>, 
   <given-names>O.</given-names>
  </string-name>, 
  <string-name>
   <surname>Enny</surname>, 
   <given-names>C.</given-names>
  </string-name>, 
  <string-name>
   <surname>Feng</surname>, 
   <given-names>H.</given-names>
  </string-name>, 
  <string-name>
   <surname>van de Velde</surname>, 
   <given-names>H.</given-names>
  </string-name> &amp; 
  <string-name>
   <surname>Viterbo</surname>, 
   <given-names>L.</given-names>
  </string-name> (
  <year>2015</year>) 
  <article-title>Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5‐year follow‐up</article-title>. 
  <source xml:lang="en">British Journal of Haematology</source>, 
  <volume>171</volume>, 
  <fpage>344</fpage>–
  <lpage>354</lpage>.
  <pub-id pub-id-type="pmid">26153365</pub-id>
 </mixed-citation>
</ref>
